0001628280-22-017338.txt : 20220616 0001628280-22-017338.hdr.sgml : 20220616 20220616144644 ACCESSION NUMBER: 0001628280-22-017338 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220615 FILED AS OF DATE: 20220616 DATE AS OF CHANGE: 20220616 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Daly James M CENTRAL INDEX KEY: 0001560782 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36783 FILM NUMBER: 221020261 MAIL ADDRESS: STREET 1: INCYTE CORPORATION EXPERIMENTAL STATION STREET 2: RTE 141 & HENRY CLAY RD. BLDG E336 CITY: WILMINGTON STATE: DE ZIP: 19880 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BELLICUM PHARMACEUTICALS, INC CENTRAL INDEX KEY: 0001358403 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 201450200 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3730 KIRBY DRIVE STREET 2: SUITE 1200 CITY: HOUSTON STATE: TX ZIP: 77098 BUSINESS PHONE: (832) 384-1100 MAIL ADDRESS: STREET 1: 3730 KIRBY DRIVE STREET 2: SUITE 1200 CITY: HOUSTON STATE: TX ZIP: 77098 FORMER COMPANY: FORMER CONFORMED NAME: BELLICUM PHARMACEUTICALS INC DATE OF NAME CHANGE: 20060405 4 1 wf-form4_165540519195576.xml FORM 4 X0306 4 2022-06-15 0 0001358403 BELLICUM PHARMACEUTICALS, INC BLCM 0001560782 Daly James M C/O BELLICUM PHARMACEUTICALS, INC. 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 1 0 0 0 Stock Option (right to buy) 1.11 2022-06-15 4 A 0 15000 0 A 2032-06-14 Common Stock 15000.0 15000 D The shares subject to the option vest and become exercisable in full on the one-year anniversary of the grant date. /s/ Richard A. Fair, Attorney-in-Fact 2022-06-16